IL136552A - Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration - Google Patents

Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration

Info

Publication number
IL136552A
IL136552A IL13655200A IL13655200A IL136552A IL 136552 A IL136552 A IL 136552A IL 13655200 A IL13655200 A IL 13655200A IL 13655200 A IL13655200 A IL 13655200A IL 136552 A IL136552 A IL 136552A
Authority
IL
Israel
Prior art keywords
solvent
viruses
nanofiltration
inactivation
detergent combination
Prior art date
Application number
IL13655200A
Other languages
English (en)
Other versions
IL136552A0 (en
Original Assignee
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11074218&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL136552(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omrix Biopharmaceuticals Ltd filed Critical Omrix Biopharmaceuticals Ltd
Priority to IL13655200A priority Critical patent/IL136552A/xx
Priority to AT01110038T priority patent/ATE364406T1/de
Priority to DE60128861T priority patent/DE60128861T2/de
Priority to ES01110038T priority patent/ES2288892T3/es
Priority to EP01110038A priority patent/EP1161958B1/en
Priority to US09/843,153 priority patent/US6468733B2/en
Priority to JP2001160562A priority patent/JP4808864B2/ja
Publication of IL136552A0 publication Critical patent/IL136552A0/xx
Publication of IL136552A publication Critical patent/IL136552A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL13655200A 2000-06-05 2000-06-05 Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration IL136552A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL13655200A IL136552A (en) 2000-06-05 2000-06-05 Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
AT01110038T ATE364406T1 (de) 2000-06-05 2001-04-26 Methode zur virusinaktivierung
DE60128861T DE60128861T2 (de) 2000-06-05 2001-04-26 Methode zur Virusinaktivierung
ES01110038T ES2288892T3 (es) 2000-06-05 2001-04-26 Un metodo para la inactivacion de virus.
EP01110038A EP1161958B1 (en) 2000-06-05 2001-04-26 A method for the inactivation of viruses
US09/843,153 US6468733B2 (en) 2000-06-05 2001-04-27 Method of the inactivation of viruses by a solvent-detergent combination and nanofiltration
JP2001160562A JP4808864B2 (ja) 2000-06-05 2001-05-29 ウイルスの不活化方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13655200A IL136552A (en) 2000-06-05 2000-06-05 Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration

Publications (2)

Publication Number Publication Date
IL136552A0 IL136552A0 (en) 2001-06-14
IL136552A true IL136552A (en) 2005-05-17

Family

ID=11074218

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13655200A IL136552A (en) 2000-06-05 2000-06-05 Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration

Country Status (7)

Country Link
US (1) US6468733B2 (es)
EP (1) EP1161958B1 (es)
JP (1) JP4808864B2 (es)
AT (1) ATE364406T1 (es)
DE (1) DE60128861T2 (es)
ES (1) ES2288892T3 (es)
IL (1) IL136552A (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
US6970740B2 (en) * 2000-04-19 2005-11-29 Clemson University UVC rediation therapy for leukemia
GB0216002D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US20040116676A1 (en) * 2002-09-30 2004-06-17 Hotta Joann Methods for removal of contaminants from blood product solutions
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
CN100384471C (zh) * 2003-02-13 2008-04-30 奥克塔法马股份有限公司 白蛋白溶液及其制备方法
ES2214967B1 (es) * 2003-03-06 2005-06-16 Probitas Pharma, S.A Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento.
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses
US20060234907A1 (en) * 2004-02-13 2006-10-19 Werner Gehringer Albumin solution and process for the production thereof
RU2411959C2 (ru) * 2004-06-29 2011-02-20 Релайанс Лайф Сайенсиз Пвт Лтд Способ получения безопасных в вирусном отношении биологических текучих сред
JP4742042B2 (ja) * 2004-06-30 2011-08-10 テルモ株式会社 ウィルス不活化ヘモグロビンおよびその製造方法
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
EP1685852A1 (en) * 2005-02-01 2006-08-02 Fondation pour la Recherche Diagnostique Set of disposable bags for viral inactivation of biological fluids
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US8354249B2 (en) * 2005-08-11 2013-01-15 Omrix Biopharmaceuticals Ltd. Intravenous immunoglobulin composition
CN100457896C (zh) * 2005-10-26 2009-02-04 李法卿 灭活生物制品中病毒和去除细菌内毒素的方法
US20070128693A1 (en) * 2005-12-06 2007-06-07 Advantek Serum Laboratories Limited3/F Method for the inactivation and removal of dengue virus from biological samples
US7960180B2 (en) * 2007-02-20 2011-06-14 University Of Notre Dame Du Lac Methods and apparatus to capture and release microbe particles using amino-functionalized silica
EP2134366A2 (en) * 2007-04-12 2009-12-23 Omrix Biopharmaceuticals Ltd. Products for prophylaxis and/or treatment of viral diseases and method of making and using same
EP2077118A1 (en) * 2008-01-07 2009-07-08 Gwo Rei Biomedical Technology Corp. Clottable concentrate of platelet growth factors and preparation method thereof
EP2373341A1 (en) 2008-12-04 2011-10-12 Omrix Biopharmaceuticals Ltd. Subcutaneous administration of anti-hepatitis b antibodies
US8945895B2 (en) * 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
RU2603103C2 (ru) * 2010-09-20 2016-11-20 Октафарма Аг Способ получения фибриногена с использованием сильной анионообменной смолы и содержащий фибриноген продукт
IL212911A0 (en) 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
MX351340B (es) 2012-03-13 2017-10-11 Octapharma Ag Proceso mejorado para la produccion de fibrinogeno y fibrinogeno producido por este.
AU2013365623B2 (en) 2012-12-20 2017-08-24 Omrix Biopharmaceuticals Ltd. Viral inactivated biological mixture
EP3651811A1 (en) * 2017-07-10 2020-05-20 Baxalta Incorporated Method for incubating liquids and inactivating viruses
EP3446710A1 (en) * 2017-08-25 2019-02-27 Glenmark Pharmaceuticals S.A. Methods of inactivating viral contaminants
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
WO2020102505A1 (en) * 2018-11-15 2020-05-22 Bayer Healthcare Llc Viral inactivation methods for continuous manufacturing of antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4789545A (en) 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US5094960A (en) 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
DE4125625C2 (de) 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
US5486293A (en) * 1994-03-21 1996-01-23 Hemasure, Inc. Removal of small exogenous molecules from biological fluids

Also Published As

Publication number Publication date
EP1161958B1 (en) 2007-06-13
DE60128861D1 (de) 2007-07-26
JP2002034556A (ja) 2002-02-05
DE60128861T2 (de) 2008-02-14
ES2288892T3 (es) 2008-02-01
EP1161958A1 (en) 2001-12-12
US6468733B2 (en) 2002-10-22
IL136552A0 (en) 2001-06-14
ATE364406T1 (de) 2007-07-15
JP4808864B2 (ja) 2011-11-02
US20020009707A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
IL136552A (en) Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
EP0755440A4 (en) NOVEL MUT VIRUSES, ANTIVIRAL COMPOUNDS, AND NOVEL VACCINE PRODUCTION METHODS
ATE304358T1 (de) (s,s)-reboxetin zur behandlung von migränekopfschmerzen
DK0758904T3 (da) Fremgangsmåder og sammensætninger til behandling af glomerulonephritis
IL189629A0 (en) Compositions containing human ctla-4 antibodies
IL154122A0 (en) Crystalline and pure modafinil, and process of preparing the same
DE60137631D1 (de) Ireovirus antikörpern zur behandlung von ras-vermittelten, proliferativen erkrankungen
NO20090583L (no) Terapi for alfa-galaktosidase A-mangel
DE69835031D1 (de) Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids
HUP0401306A2 (hu) Eljárás gyomok irtására
DE60042035D1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
PL370518A1 (en) Process for the treatment of molybdenum concentrate
AU2001232267A1 (en) Remedies for hepatitis c
ATE555194T1 (de) Methode zur herstellung von proliferierenden und differenzierenden zelllinien
DE60227517D1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
WO2003049765A3 (en) Enveloped virus vaccine and method for production
NO971567L (no) Fremgangsmåte for rensing av keratinocyttvekstfaktorer
AU1681095A (en) Hydrophilic signal oligopeptides and methods of therapeutic use
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
DK78990A (da) Fremgangsmaade til rensning af ydre membran protein for haemophilus influenza
ATE462791T1 (de) Parvovirus ns1 varianten
DE60124791D1 (de) S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen.
DE69917574D1 (de) Methode zur Immobilisierung von Verbindungen
DE59607190D1 (de) Membranelement, damit ausgerüstetes Membranventil und Verfahren zur Herstellung des Membranelements
DE60201223D1 (de) Verfahren zur Herstellung von 3,4-Dihydroxybenzonitril

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired